使AIGluN1/GluN3ANMDA

Shi-Wei Li1, Yue Zeng2,3,4, Sa-Nan Wu1

  • 1Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.

PubMed
概括

研究人员开发了一种人工智能驱动的管道,以找到GluN1/GluN3A受体的抑制剂,这对于情绪调节至关重要. 这种方法成功地确定了强效和选择性化合物,推进了潜在的N-甲基-D-酸盐受体 (NMDAR) 治疗方法.